Enterococcus peptidoglycan remodeling promotes immune checkpoint inhibitor therapy
M. E. Griffin, J. Espinosa, J. L. Becker, J. K. Jha, G. R. Fanger, H. C. Hang
The paper shows that Enterococcus species enhance immune checkpoint inhibitor therapy by remodeling peptidoglycan and activating Nod2.
bioRxiv · Aug 20, 2020Cancer Biology